|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,800.00 KRW | +2.13% |
|
+8.72% | -29.62% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.13% | +8.72% | -46.67% | - | 74.17M | ||
| +1.10% | +6.65% | +72.68% | +481.31% | 40B | ||
| +1.09% | +5.71% | +9.58% | +37.02% | 23.53B | ||
| +0.68% | +1.96% | -20.79% | -39.09% | 7.28B | ||
| +4.77% | +13.19% | +22.33% | +122.64% | 5.41B | ||
| -0.28% | -2.58% | +15.53% | +43.76% | 2.89B | ||
| -5.86% | -3.31% | -26.31% | +1,059.97% | 2B | ||
| +1.27% | +6.99% | +100.79% | -2.70% | 1.97B | ||
| -0.44% | +7.04% | +38.49% | -20.43% | 1.82B | ||
| +2.08% | +0.70% | +20.74% | -4.44% | 1.65B | ||
| Average | +0.65% | +4.09% | +18.64% | +186.45% | 8.66B | |
| Weighted average by Cap. | +1.07% | +6.85% | +39.18% | +262.29% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















